title: Letter: telmisartan-associated enteropathy - is there any class effect?
authors.affiliation: 2nd Department of Internal Medicine - Gastroenterology, Charles University in Prague, Faculty of Medicine in Hradec Kralove, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic. jiri.cyrany@fnhk.cz.
authors.forename: J
authors.initials: J
authors.lastname: Cyrany
authors.forename: T
authors.initials: T
authors.lastname: Vasatko
authors.forename: J
authors.initials: J
authors.lastname: Machac
authors.forename: M
authors.initials: M
authors.lastname: Nova
authors.forename: J
authors.initials: J
authors.lastname: Szanyi
authors.forename: M
authors.initials: M
authors.lastname: Kopacova
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects*; D002446:Celiac Disease / Q000139:chemically induced*; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D013777:Tetrazoles / Q000009:adverse effects*
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D007093:Imidazoles; D013777:Tetrazoles